Cardiovascular events and COX-2 inhibitors

JAMA. 2001 Dec 12;286(22):2810; author reply 2811-2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Aspirin / therapeutic use
  • C-Reactive Protein / metabolism
  • Cardiovascular Diseases / epidemiology*
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Drug Synergism
  • Humans
  • Isoenzymes / antagonists & inhibitors*
  • Membrane Proteins
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Prostaglandin-Endoperoxide Synthases
  • Risk
  • Thrombosis / epidemiology

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Membrane Proteins
  • Platelet Aggregation Inhibitors
  • C-Reactive Protein
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • PTGS1 protein, human
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Aspirin